The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy

Nytko, KJ; Grgic, I; Bender, S; Ott, J; Guckenberger, M; Riesterer, O; Pruschy, M

Pruschy, M (reprint author), Univ Zurich Hosp, Dept Radiat Oncol, Lab Appl Radiobiol, Zurich, Switzerland.; Pruschy, M (reprint author), Clin Res Prior Program Tumor Oxygenat, Zurich, Switzerland.

ONCOTARGET, 2017; 8 (14): 23702

Abstract

The promising treatment combination of ionizing radiation (IR) with a hypoxia-activated prodrug (HAP) is based on biological cooperation. Here we inve......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索